glp-1 fatty liver disease The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis Sodium butyrate reduces high-fat diet-induced

[DOI] [PMC free article] [PubMed] [Google Scholar] 56.Nexe-Larsen C.C., Srensen P.H., Hausner H., Agersnap M., Baekdal M., Brnden A., Gustafsson L.N., Sonne D.P., Vedtofte L., Vilsbll T., et al

Ozempic and Wegovy contain semaglutide, which works by mimicking a hormone called GLP-1 that helps regulate appetite and blood sugar

Common side effects include nausea, diarrhea, dry mouth, fatigue, and changes in appetite

Recent studies using GLP1R/GIPR dual agonists, especially the SURPASS clinical trials, have revealed beneficial effects of GIP activation when used in conjunction with GLP-1RAs

This would be particularly impactful for patients who have struggled with traditional treatments or who face fertility issues related to obesity and metabolic disorders

Adding smaller portions is easy